ArticleFrontiers in cell and developmental biology2021

Inhibition of miR-185-3p Confers Erlotinib Resistance Through Upregulation of PFKL/MET in Lung Cancers.

Ke Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.